RT Journal Article SR Electronic T1 Anaemic women are more at risk of injectable contraceptive discontinuation due to side-effects in Ethiopia JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.10.28.20221523 DO 10.1101/2020.10.28.20221523 A1 Rose Stevens A1 Blandine Malbos A1 Eshetu Gurmu A1 Jérémie Riou A1 Alexandra Alvergne YR 2020 UL http://medrxiv.org/content/early/2020/10/30/2020.10.28.20221523.abstract AB Introduction This paper investigates the importance of women’s physiological condition for predicting the risk of discontinuation due to side-effects of the injectable contraceptive in Ethiopia, where side-effects account for around 20% of all discontinuations.Methods Contraceptive calendar data from the 2016 Ethiopian Demographic and Health Survey were analysed. Women aged 15-49 who had initiated the injectable contraceptive in the two years prior to interview were included in the analysis (N=1,513). After checking for reverse causality, the associations between physiological risk factors and discontinuation of the injectable contraceptive due to either side-effects (DSE) or other reasons (DOR) were estimated using multivariate Cox proportional regression analyses.Results In 2016, 10% of women had initiated the injectable in the last two years, and 1 in 4 had discontinued use by the time of the interview. Of these, 1 in 5 discontinued due to side-effects. Women with anaemia were at twice the risk of DSE compared with non-anaemic women, while anaemia status was not associated with DOR. The association between anaemia and experience of side-effects is likely driven by iron-deficiency anaemia, as having taken iron supplements during last pregnancy is found to decrease the risk of DSE. Sociocultural factors including religion, wealth and relationship status were significant predictors for DOR, but not for DSE.Conclusion Accounting for diversity in physiological condition is key for understanding contraceptive discontinuation due to side-effects. To reduce side-effects and thereby unmet need for contraception, family planning programs may benefit from providing an integrated service package addressing anaemia as well as supplying hormonal contraception.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo specific funding was obtained for this research. RS is undertaking graduate study, funded by an Economic and Social Research Council studentship (Grant Number: ES/P000649/1), as part of which, she conducted this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Procedures and questionnaires for standard DHS surveys have been approved by the ICF Institutional Review Board (IRB) and the specific Ethiopian protocol by IRBs in Ethiopia.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available upon request from the Demographic and Health Survey website (https://dhsprogram.com/). https://dhsprogram.com/